CLOZAPINE - A NOVEL ANTIPSYCHOTIC AGENT

[1] AGRANULOCYTOSIS IN PATIENTS TREATED WITH CLOZAPINE - STUDY OF FINNISH EPIDEMIC [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1977, 56 (04) : 241 - 248

[2] EFFECT OF CLOZAPINE ON TURNOVER OF DOPAMINE IN CORPUS STRIATUM AND IN LIMBIC SYSTEM [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (04) : 346 - 348

[3] CLOZAPINE-INDUCED AGRANULOCYTOSIS - SITUATION REPORT UP TO AUGUST 1976 [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 11 (03) : 199 - 201

[4] EVIDENCE FOR DIFFERENT STATES OF THE DOPAMINE D1 RECEPTOR - CLOZAPINE AND FLUPERLAPINE MAY PREFERENTIALLY LABEL AN ADENYLATE CYCLASE-COUPLED STATE OF THE D1-RECEPTOR [J]. JOURNAL OF NEUROCHEMISTRY, 1986, 47 (06) : 1822 - 1831

[5] ALTERATIONS OF CEREBROSPINAL-FLUID 5-HYDROXYINDOLEACETIC ACID, AND TOTAL BLOOD SEROTONIN CONTENT DURING CLOZAPINE TREATMENT [J]. PSYCHOPHARMACOLOGY, 1978, 56 (02) : 195 - 198

[6] RESULTS AND SIDE-EFFECTS OF TREATMENT WITH CLOZAPINE (LEPONEX R) [J]. COMPREHENSIVE PSYCHIATRY, 1977, 18 (05) : 423 - 428

[7] CHRONIC TREATMENT WITH CLASSICAL AND ATYPICAL ANTIPSYCHOTIC-DRUGS DIFFERENTIALLY DECREASES DOPAMINE RELEASE IN STRIATUM AND NUCLEUS-ACCUMBENS INVIVO [J]. NEUROSCIENCE LETTERS, 1987, 78 (02) : 199 - 204

[8] EFFECTS OF CLOZAPINE, THIORIDAZINE, PERLAPINE AND HALOPERIDOL ON METABOLISM OF BIOGENIC-AMINES IN BRAIN OF RAT [J]. PSYCHOPHARMACOLOGIA, 1975, 41 (01): : 27 - 33

[9] BURKI HR, 1975, PHARMAKOPSYCH NEURO, V8, P115

[10] EFFECT OF SINGLE AND REPEATED ADMINISTRATION OF CLOZAPINE ON METABOLISM OF DOPAMINE AND NORADRENALINE IN BRAIN OF RAT [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1974, 27 (02) : 180 - 190

[1] AGRANULOCYTOSIS IN PATIENTS TREATED WITH CLOZAPINE - STUDY OF FINNISH EPIDEMIC [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1977, 56 (04) : 241 - 248

[2] EFFECT OF CLOZAPINE ON TURNOVER OF DOPAMINE IN CORPUS STRIATUM AND IN LIMBIC SYSTEM [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (04) : 346 - 348

[3] CLOZAPINE-INDUCED AGRANULOCYTOSIS - SITUATION REPORT UP TO AUGUST 1976 [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 11 (03) : 199 - 201

[4] EVIDENCE FOR DIFFERENT STATES OF THE DOPAMINE D1 RECEPTOR - CLOZAPINE AND FLUPERLAPINE MAY PREFERENTIALLY LABEL AN ADENYLATE CYCLASE-COUPLED STATE OF THE D1-RECEPTOR [J]. JOURNAL OF NEUROCHEMISTRY, 1986, 47 (06) : 1822 - 1831

[5] ALTERATIONS OF CEREBROSPINAL-FLUID 5-HYDROXYINDOLEACETIC ACID, AND TOTAL BLOOD SEROTONIN CONTENT DURING CLOZAPINE TREATMENT [J]. PSYCHOPHARMACOLOGY, 1978, 56 (02) : 195 - 198

[6] RESULTS AND SIDE-EFFECTS OF TREATMENT WITH CLOZAPINE (LEPONEX R) [J]. COMPREHENSIVE PSYCHIATRY, 1977, 18 (05) : 423 - 428

[7] CHRONIC TREATMENT WITH CLASSICAL AND ATYPICAL ANTIPSYCHOTIC-DRUGS DIFFERENTIALLY DECREASES DOPAMINE RELEASE IN STRIATUM AND NUCLEUS-ACCUMBENS INVIVO [J]. NEUROSCIENCE LETTERS, 1987, 78 (02) : 199 - 204

[8] EFFECTS OF CLOZAPINE, THIORIDAZINE, PERLAPINE AND HALOPERIDOL ON METABOLISM OF BIOGENIC-AMINES IN BRAIN OF RAT [J]. PSYCHOPHARMACOLOGIA, 1975, 41 (01): : 27 - 33

[9] BURKI HR, 1975, PHARMAKOPSYCH NEURO, V8, P115

[10] EFFECT OF SINGLE AND REPEATED ADMINISTRATION OF CLOZAPINE ON METABOLISM OF DOPAMINE AND NORADRENALINE IN BRAIN OF RAT [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1974, 27 (02) : 180 - 190